Jan Bogaerts
European Organisation for Research and Treatment of Cancer · 195 works · 55,270 citations · h-index 50
Top works
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
- Individual patient data analysis to assess modifications to the RECIST criteria
- Evaluation of lymph nodes with RECIST 1.1
- iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics
- Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial
- 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
- Validation and Clinical Utility of a 70-Gene Prognostic Signature for Women With Node-Negative Breast Cancer
- RECIST 1.1—Update and clarification: From the RECIST committee
- ESMO-Magnitude of Clinical Benefit Scale version 1.1
- Breast-Conserving Treatment With or Without Radiotherapy in Ductal Carcinoma-In-Situ: Ten-Year Results of European Organisation for Research and Treatment of Cancer Randomized Phase III Trial 10853—A Study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group
- Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials
- Gene signature evaluation as a prognostic tool: challenges in the design of the MINDACT trial
- A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer
- Phase III Comparative Study of High-Dose Cisplatin Versus a Combination of Paclitaxel and Cisplatin in Patients With Advanced Non–Small-Cell Lung Cancer
- Breast conserving therapy versus mastectomy for stage I–II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial
- Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial
- Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data
- Phase 3 Randomized Trial on Larynx Preservation Comparing Sequential vs Alternating Chemotherapy and Radiotherapy
- The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1–3 positive lymph nodes in an independent validation study